Company Filing History:
Years Active: 2020-2022
Title: Innovations by James Rhoads in Cancer Detection
Introduction
James Rhoads is an accomplished inventor based in Des Plaines, IL (US). He has made significant contributions to the field of cancer detection through his innovative technologies. With a total of 2 patents, Rhoads has focused on developing methods that enhance the detection of molecular markers relevant to cancer.
Latest Patents
Rhoads' latest patents include advancements in the EGFR assay. This technology is designed to detect molecular markers associated with cancer, specifically focusing on methods and compositions for quantifying and detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples. His work in this area is crucial for improving cancer diagnostics and treatment options.
Career Highlights
James Rhoads is currently employed at Abbott Molecular Inc., where he continues to innovate in the field of molecular diagnostics. His expertise and dedication to cancer research have positioned him as a valuable asset in the medical technology industry.
Collaborations
Rhoads has collaborated with notable colleagues, including Jeffrey D. Wuitschick and Kevin S. Nelson. These partnerships have further enhanced his research and development efforts in cancer detection technologies.
Conclusion
James Rhoads is a prominent inventor whose work in cancer detection has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical technology.